Philips open 1T goes commercial

Article

Images obtained using the new Panorama 1T open MR scanner equal or surpass the quality of cylindrical 1.5T systems, according to developer Philips Medical Systems. The first of this breed of scanner began operating in mid-October at a Las Vegas outpatient clinic owned by Nevada Imaging Centers. It is not the first open 1T to enter clinical service; Siemens Medical Solutions has installed three 1T Rhapsody systems at clinical sites. The Panorama 1T, however, is the only truly high-field open MR designed for mass production. Routine deliveries of the system, which was shown at this year's RSNA meeting, are scheduled to begin in 2005.

Images obtained using the new Panorama 1T open MR scanner equal or surpass the quality of cylindrical 1.5T systems, according to developer Philips Medical Systems. The first of this breed of scanner began operating in mid-October at a Las Vegas outpatient clinic owned by Nevada Imaging Centers. It is not the first open 1T to enter clinical service; Siemens Medical Solutions has installed three 1T Rhapsody systems at clinical sites. The Panorama 1T, however, is the only truly high-field open MR designed for mass production. Routine deliveries of the system, which was shown at this year's RSNA meeting, are scheduled to begin in 2005.

The scanner is designed to produce images as good and as fast as those acquired at 1.5T, while offering the patient the benefits of an open design. The actively shielded vertical-field superconducting magnet operates on the same platform as the company's cylindrical Achieva, but it relies on specially designed coils that are more efficient than those for the traditional horizontal cylindrical field systems, according to the company. A wheeled patient table that docks with the scanner boosts throughput: A site purchasing two such tables can use one to prepare a patient while the other is docked to the scanner. (Provided by Philips Medical Solutions)

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.